Amy Rosenberg

Amy Rosenberg serves as the Senior Director of Immunology and Consultant at EpiVax, Inc. since September 2021. Prior to this role, Amy held significant positions at the US FDA, including Director of the Division of Biologics Research and Review III in the Office of Biotechnology Products, CDER from June 2014 to September 2021, and Director of the Division of Therapeutic Proteins in CDER from November 1999 to June 2014. Amy's education includes a Doctor of Medicine degree obtained from Albert Einstein College of Medicine, with additional studies at New York University and the National Institutes of Health.